Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

OTCPK:EMMBF - Post Discussion

Emblem Corp > re:warrants
View:
Post by ilvmyt5s on Jan 23, 2019 2:43pm

re:warrants

posted on the TBP board thougth I was on EMC

Warrants are undervalued by half. The market cap will double with the deal but the warrants have fallen by half??? The warrant structures remain the same except the payout is a ratio from the new entity. I think some were confused and sold; the new warrants should be around .20 to .25 after the deal goes through wrt market cap.
Comment by GrahamCracker on Jan 24, 2019 6:20am
According to this recent pump article analysts are very bullish on Emblem/Aleafia together...  299% higher target price.  Warrants are extremely attractive right now at these prices. https://www.fool.com/investing/2019/01/23/5-pot-stocks-wall-street-believes-will-double.aspx
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities